UTI
More informed treatment decisions
in less than one day†
Precision diagnostic testing with rapid results for the management of complicated, recurrent or persistent
UTIs and elevated risk patients
UTIs and elevated risk patients
ORGANISM IDENTIFICATION (PCR)
27 individual organisms and 3 bacterial groups, developed using an evidence based analysis of uropathogens
RESISTANCE GENE DETECTION (PCR)
27 individual organisms and 3 bacterial groups, developed using an evidence based analysis of uropathogens
RESISTANCE GENE DETECTION (PCR)
27 individual organisms and 3 bacterial groups, developed using an evidence based analysis of uropathogens
GUIDANCE UTI
27 individual organisms and 3 bacterial groups, developed using an evidence based analysis of uropathogens
MySmartCare360® UTI is an advanced test that better addresses
polymicrobial infections in difficult cases where bacterial
interactions can impact antibiotic resistance.
polymicrobial infections in difficult cases where bacterial
interactions can impact antibiotic resistance.
ADVANTAGE RAPID RESULTS
MySmartCare360® UTI provides personalized results in less than one day from receipt at lab, while culture can take 3-5 days, reducing the need for empiric therapy and supporting antibiotic stewardship initiatives.
Results are summarized in an easy- to-read report showing therapy options based on the patient’s individual infection.
ADVANTAGE IMPROVED SENSITIVITY
MySmartCare360® UTI uses PCR technology to identify commonly tested uropathogens, including fastidious bacteria and yeasts, that are difficult to detect by culture. MySmartCare360 UTI has demonstrated 95% sensitivity when identifying organisms, which is 43% more sensitive than culture.1 High sensitivity helps ensure accurate pathogen identification and UTI diagnosis.
ADVANTAGE BETTER ADDRESSES POLYMICROBIAL UTIS
MySmartCare360® UTI identifies specific pathogenic organisms and effective treatments for polymicrobial infections, which have been shown to occur in up to 52% of positive cases.1 While culture may return these results as “contaminated” or “mixed flora”, MySmartCare360 UTI identifies the specific uropathogens in the specimen – even when multiple organisms are present.
ADVANTAGE ALLOWS FOR MORE INFORMED TREATMENT DECISIONS
Rather than relying on resistance gene information alone, MySmartCare360® UTI provides personalized therapy options by using Pooled Antibiotic Susceptibility Testing (P-AST™), a unique technology that accounts for bacterial interactions that occur in polymicrobial infections that may alter antibiotic resistance.2
Real World Evidence
MySmartCare360® UTI testing is associated with reductions in critical adverse outcomes, healthcare resource utilization
and cost for complicated (cUTI).
and cost for complicated (cUTI).
13%
lower rate of outpatient emergency visits
$463.46
savings per cUTI patient tested with
MySmartCare360 UTI (p=0.043)
MySmartCare360 UTI (p=0.043)
67%
lower inpatient admissions rate
42%
reduction in visits to emergency department, inpatient hospital, urgent care and SNF
NO
urosepsis, urgent care and skilled nursing facility admissions for every 1,000 patients in this study
$11.6 MIL SAVINGS
for 25,000 cUTI cases
Reference: Aparna Ashok, Dicken Ko, Providence RI, Emily Lukacz, La Jolla, CA, Annah Vollstedt, Iowa City, IA, Iver Juster, San Rafael, CA, Timothy Niecko, Tierra Verde, FL, David Baunoch, Trabuco Canyon, CA, Mohit Mathur, Irvine, CA. Comparison of MySmartCare360® UTI and standard urine culture for rates of sepsis, hospitalization and other adverse outcomes in complicated urinary tract infections [abstract]. Journal of Urology. AUA Annual Meeting Program Abstracts 2022. 1 May 2022. Volume 207 Issue Supplement 5 May 2022.
The same MySmartCare360® UTI results
you trust, from the comfort of
home
Whether it’s busy schedules, limited mobility, or the patient was simply unable to leave a sample at the time of the office visit, incorporating MySmartCare360® UTI testing from the comfort of home can facilitate access to care as well as reduce the risk of exposure for both patients and providers. After a provider places an order for a home kit, the Pathnostics team will take it from there!
Patient Assessment
The provider determines if MySmartCare360® UTI testing is appropriate for the patient.
Fast turnaround time
Once received at the lab, MySmartCare360® UTI home kits have the same less than one day†
One step ordering
The provider completes a MySmartCare360® UTI test requisition and faxes it
Signature service
Pathnostics will call each patient to review specimen collection instructions, coordinate
ADVANTAGE RAPID RESULTS
Guidance® UTI provides personalized results in less than one day from receipt at lab, while culture can take 3-5 days, reducing the need for empiric therapy and supporting antibiotic stewardship initiatives.
Results are summarized in an easy- to-read report showing therapy options based on the patient’s individual infection.
ADVANTAGE IMPROVED SENSITIVITY
Guidance® UTI uses PCR technology to identify commonly tested uropathogens, including fastidious bacteria and yeasts, that are difficult to detect by culture. Guidance UTI has demonstrated 95% sensitivity when identifying organisms, which is 43% more sensitive than culture.1 High sensitivity helps ensure accurate pathogen identification and UTI diagnosis.
ADVANTAGE BETTER ADDRESSES POLYMICROBIAL UTIS
Guidance® UTI identifies specific pathogenic organisms and effective treatments for polymicrobial infections, which have been shown to occur in up to 52% of positive cases.1 While culture may return these results as “contaminated” or “mixed flora”, Guidance UTI identifies the specific uropathogens in the specimen – even when multiple organisms are present.
ADVANTAGE ALLOWS FOR MORE INFORMED TREATMENT DECISIONS
Rather than relying on resistance gene information alone, Guidance® UTI provides personalized therapy options by using Pooled Antibiotic Susceptibility Testing (P-AST™), a unique technology that accounts for bacterial interactions that occur in polymicrobial infections that may alter antibiotic resistance.2
Get MySmartCare360® UTI now
Ready to provide your patients with personalized therapy right from the start?
